VOIANT℠
James S. Primerano, Jr. has extensive work experience in the healthcare industry. James S. is currently the Chief Executive Officer at VOIANT™ since 2023. Prior to this, they served as the Chief Executive Officer at WorldCare Clinical from 2022 to 2023. Between 2014 and 2021, they held the position of Senior Vice President and General Manager, eClinical at Signant Health. Additionally, they worked at Bracket as the Vice President, eClinical Delivery from 2012 to 2013 and as the Executive Director, Client Services, eClinical from 2011 to 2012. Before that, they held roles at United BioSource Corporation as the Senior Director, Operations from 2011 to 2011 and the Director, Strategic Operations from 2009 to 2011. James S. also worked at Medidata Solutions as the Senior Director, Product Strategy from 2007 to 2009. Furthermore, they co-founded Quatern and served as the Executive Vice President & COO from 2005 to 2007. James S. started their career as a Clinical Research Associate at Covance from 1998 to 2000.
James S. Primerano, Jr. obtained a Bachelor of Arts degree in Biology from the University of Pennsylvania, where they studied from 1993 to 1997. James S. furthered their education by pursuing a Master of Business Administration (MBA) in Global Business at Rider University, which they completed between 1999 and 2002.
This person is not in any offices
VOIANT℠
Three industry leading companies, MedQIA, WorldCare Clinical and DARC, have come together to form Voiant, the new leader in clinical trial imaging endpoint data. We are the industry leading AI-based clinical trial imaging solution with unparalleled scientific and clinical domain expertise, providing biopharmaceutical companies with high-speed delivery of quality clinical endpoint data. We combine leadership in artificial intelligence and visionary computing, key opinion leaders for strategic therapeutic areas alignment and clinical research experts to deliver operational excellence and consistent execution - providing the shortest path to the highest quality imaging data for clinical trials.